Compare ImmunityBio Inc. Common Stock (IBRX) vs Plug Power Inc (PLUG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Plug Power Inc — how do they compare? ImmunityBio Inc. Common Stock trades at $10.51 (market cap $10.51B), while Plug Power Inc trades at $1.68 (market cap $2.42B). The key difference: ImmunityBio Inc. Common Stock is far larger — about 4.3× Plug Power Inc's market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, Plug Power Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 1 Days and Plug Power Inc for 41 Days on average.
| IBRX | PLUG | |
|---|---|---|
Market Cap | $10.51B | $2.42B |
Volume | 10,445,785 | 53,851,702 |
Sector | Health | Industrials |
52-Week High | $11.55 | $4.14 |
52-Week Low | $1.98 | $1.73 |
Typical Hold Time | 1 Days | 41 Days |
Enterprise Value | $10.97B | $3.29B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Plug Power (PLUG) trades at $1.73, down 2.81% on the day, reflecting persistent financial challenges. The stock exhibits a bearish technical trend with negative moving averages, though oversold oscillators suggest potential for a near-term bounce. Fundamentally, the company continues to report significant losses, with a net income margin of -220.59% and negative cash flow from operations of $535.84 million in 2025. Recent news highlights strategic partnerships, such as a 280 MW electrolyzer supply agreement with Arcadia eFuels, aiming to expand its green hydrogen footprint.
The outlook remains highly speculative, with substantial execution risks and cash burn offset by growth potential in the hydrogen sector. Analyst consensus is mixed, with a $3.13 price target implying upside, but the stock's proximity to the low target of $1.65 underscores vulnerability. Investors face high volatility and dilution risk given ongoing financing needs, making it suitable only for those with high risk tolerance and a long-term view on hydrogen adoption.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Plug Power Inc
Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets—including material handling, e-mobility, power generation, and industrial applications.
Read more on PLUG →
